Published in Viruses on October 16, 2012
Arenavirus reverse genetics for vaccine development. J Gen Virol (2013) 0.83
Differential contributions of tacaribe arenavirus nucleoprotein N-terminal and C-terminal residues to nucleocapsid functional activity. J Virol (2014) 0.78
Structure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppression. Acta Crystallogr D Biol Crystallogr (2014) 0.75
Reverse Genetics Approaches to Control Arenavirus. Methods Mol Biol (2016) 0.75
Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses. Viruses (2016) 0.75
Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein. Virology (2016) 0.75
A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med (2008) 7.73
Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38
Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med (2006) 5.42
Web services at the European bioinformatics institute. Nucleic Acids Res (2007) 4.48
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods (1991) 3.78
Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. Science (2006) 3.70
Crystal structure of the rabies virus nucleoprotein-RNA complex. Science (2006) 3.48
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A (2001) 3.43
The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A (2003) 3.34
Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature (2010) 2.87
Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol (2003) 2.87
NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol (2000) 2.74
Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science (2009) 2.71
Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2006) 2.61
Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36
Human infection with arenaviruses in the Americas. Curr Top Microbiol Immunol (2002) 2.32
Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol (2002) 2.32
Crystal structure of the borna disease virus nucleoprotein. Structure (2003) 2.30
Lassa virus. Crit Rev Clin Lab Sci (2004) 2.27
Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A (2011) 2.12
Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. FASEB J (2008) 2.10
Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol (2002) 1.97
Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol (2007) 1.95
Conformations of amino acids in proteins. Acta Crystallogr D Biol Crystallogr (2002) 1.95
Arenaviruses other than Lassa virus. Antiviral Res (2003) 1.86
Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs. J Virol (2001) 1.80
Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A (2009) 1.72
Functional mapping of the nucleoprotein of Ebola virus. J Virol (2006) 1.69
Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J Virol (2003) 1.69
Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2009) 1.61
Myristoylation of the RING finger Z protein is essential for arenavirus budding. J Virol (2004) 1.58
Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2003) 1.56
Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res (2004) 1.54
Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc Natl Acad Sci U S A (2011) 1.51
Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol (2009) 1.50
Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis (1997) 1.48
Lymphocytic choriomeningitis virus and immunology. Curr Top Microbiol Immunol (2002) 1.45
Viral hemorrhagic fever hazards for travelers in Africa. Clin Infect Dis (2001) 1.45
Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J Virol (2005) 1.40
Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J Virol (2005) 1.36
Arenaviruses: genomic RNAs, transcription, and replication. Curr Top Microbiol Immunol (2002) 1.35
The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol J (2006) 1.27
Molecular organization of Junin virus S RNA: complete nucleotide sequence, relationship with other members of the Arenaviridae and unusual secondary structures. J Gen Virol (1991) 1.27
Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever. Antimicrob Agents Chemother (1988) 1.26
Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε. J Virol (2012) 1.15
Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. J Virol (2012) 1.14
Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses (2010) 1.11
Identification of two functional domains within the arenavirus nucleoprotein. J Virol (2010) 1.10
A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J Virol (2010) 1.10
Murine coronavirus delays expression of a subset of interferon-stimulated genes. J Virol (2010) 1.05
Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J Virol (2010) 1.03
[Prenatal infection with the virus of lymphocytic choriomeningitis: report of two cases (author's transl)]. Dtsch Med Wochenschr (1974) 1.02
A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding. Virology (2008) 0.97
Cross-species analysis of the replication complex of Old World arenaviruses reveals two nucleoprotein sites involved in L protein function. J Virol (2011) 0.96
Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses. Ann N Y Acad Sci (2009) 0.95
A novel high-throughput cell-based method for integrated quantification of type I interferons and in vitro screening of immunostimulatory RNA drug delivery. Biotechnol Bioeng (2009) 0.88
Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function. J Virol (2012) 0.88
[Main syndrome of prenatal infection caused by lymphocytic choriomeningitis virus - hydrocephalus and chorioretinal degeneration]. Pediatriia (1976) 0.76
Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol (2006) 4.88
Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol (2005) 4.31
Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol (2006) 3.84
Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol (2007) 3.53
The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A (2003) 3.34
Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol (2006) 2.78
Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci U S A (2007) 2.33
Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res (2007) 2.21
Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol (2005) 1.96
RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc Natl Acad Sci U S A (2010) 1.94
Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A (2009) 1.72
Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med (2008) 1.72
Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell (2012) 1.70
Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol (2008) 1.64
Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2009) 1.61
Rescue of the prototypic Arenavirus LCMV entirely from plasmid. Virology (2006) 1.58
The intracellular sites of early replication and budding of SARS-coronavirus. Virology (2007) 1.53
Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res (2007) 1.53
Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc Natl Acad Sci U S A (2011) 1.47
Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. J Virol (2007) 1.41
Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring. J Neurosci (2011) 1.36
Arenavirus Z-glycoprotein association requires Z myristoylation but not functional RING or late domains. J Virol (2007) 1.27
Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins. MBio (2011) 1.22
Thogoto virus ML protein suppresses IRF3 function. Virology (2005) 1.19
Protection against lethal influenza with a viral mimic. J Virol (2013) 1.18
Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. Mol Ther (2009) 1.18
Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε. J Virol (2012) 1.15
Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E. Proc Natl Acad Sci U S A (2010) 1.14
Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. J Virol (2012) 1.14
Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response. J Virol (2010) 1.13
Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses (2010) 1.11
Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology (2011) 1.10
Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J Med Virol (2008) 1.07
Genetic and biochemical evidence for an oligomeric structure of the functional L polymerase of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2005) 1.05
Murine coronavirus delays expression of a subset of interferon-stimulated genes. J Virol (2010) 1.05
Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. J Gen Virol (2009) 1.04
Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J Virol (2010) 1.03
Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR. PLoS Pathog (2009) 1.03
Arenavirus genetic diversity and its biological implications. Infect Genet Evol (2009) 1.03
Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope. PLoS Pathog (2012) 0.99
Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors. ACS Chem Biol (2013) 0.98
Identification of host factors involved in borna disease virus cell entry through a small interfering RNA functional genetic screen. J Virol (2010) 0.94
Cell entry of Borna disease virus follows a clathrin-mediated endocytosis pathway that requires Rab5 and microtubules. J Virol (2009) 0.93
Cell-to-cell spread of Borna disease virus proceeds in the absence of the virus primary receptor and furin-mediated processing of the virus surface glycoprotein. J Virol (2007) 0.91
Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. J Gen Virol (2009) 0.90
A novel high-throughput cell-based method for integrated quantification of type I interferons and in vitro screening of immunostimulatory RNA drug delivery. Biotechnol Bioeng (2009) 0.88
Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function. J Virol (2012) 0.88
Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry. J Virol (2009) 0.87
Novel antiviral strategies to combat human Arenavirus infections. Curr Mol Med (2005) 0.86
Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus. J Virol (2013) 0.85
Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor. J Gen Virol (2009) 0.84
Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus. J Virol (2007) 0.84
Arenavirus reverse genetics for vaccine development. J Gen Virol (2013) 0.83
Sodium hydrogen exchangers contribute to arenavirus cell entry. J Virol (2013) 0.82
Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells. J Vis Exp (2013) 0.82
Host-range restriction of vaccinia virus E3L deletion mutant can be overcome in vitro, but not in vivo, by expression of the influenza virus NS1 protein. PLoS One (2011) 0.82
Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor. J Virol (2013) 0.81
Epitope mapping of human respiratory syncytial virus 22K transcription antitermination factor: role of N-terminal sequences in protein folding. J Gen Virol (2005) 0.80
Design, synthesis, and biological evaluation of a biyouyanagin compound library. Proc Natl Acad Sci U S A (2011) 0.79
Regulation of PURA gene transcription by three promoters generating distinctly spliced 5-prime leaders: a novel means of fine control over tissue specificity and viral signals. BMC Mol Biol (2010) 0.78
Rescue of recombinant Newcastle disease virus from cDNA. J Vis Exp (2013) 0.78
Arenavirus Quasispecies and Their Biological Implications. Curr Top Microbiol Immunol (2016) 0.75